BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12439840)

  • 1. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C; Del Vecchio L; Locatelli F
    G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D; Ahuja M; Shortland JR; Brown CB
    Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin converting enzyme inhibitor and chronic renal failure.
    Sitprija V; Lumlertgul D
    J Med Assoc Thai; 1993 Jul; 76(7):359-67. PubMed ID: 8089635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic advantages of angiotensin converting enzyme inhibitors in chronic renal disease.
    Omata K; Kanazawa M; Sato T; Abe F; Saito T; Abe K
    Kidney Int Suppl; 1996 Jun; 55():S57-62. PubMed ID: 8743512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The late results of treating membranous glomerulonephritis].
    Belovezhdov N; Robeva R; Dimitrova V
    Vutr Boles; 1990; 29(3):53-60. PubMed ID: 2284800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P; Frey FJ
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs.
    Austin HA; Klippel JH; Balow JE; le Riche NG; Steinberg AD; Plotz PH; Decker JL
    N Engl J Med; 1986 Mar; 314(10):614-9. PubMed ID: 3511372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytostatic treatment of glomerular diseases. IV. The effect of combined immunosuppressive treatment on serum creatinine and proteinuria evaluated by sequential statistical analysis. Report from a Copenhagen study group of renal diseases.
    Balsløv JT; Brun C; Jørgensen F; Jørgensen HE; Larsen M; Larsen S; Lorenzen I; Thomsen AC
    Acta Med Scand; 1978; 203(5):339-44. PubMed ID: 352097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid therapy in IgA nephropathy with nephrotic syndrome: a long-term controlled trial.
    Lai KN; Lai FM; Ho CP; Chan KW
    Clin Nephrol; 1986 Oct; 26(4):174-80. PubMed ID: 3536231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effect of urokinase therapy in IgA nephropathy.
    Miura M; Endoh M; Nomoto Y; Sakai H
    Clin Nephrol; 1989 Nov; 32(5):209-16. PubMed ID: 2510959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
    Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases.
    Kobayashi Y; Fujii K; Hiki Y; Tateno S
    Q J Med; 1986 Oct; 61(234):935-43. PubMed ID: 3628707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alternate-day prednisone therapy in IgA nephropathy. Preliminary analysis of a prospective, randomized, controlled trial.
    Julian BA; Barker C
    Contrib Nephrol; 1993; 104():198-206. PubMed ID: 8325030
    [No Abstract]   [Full Text] [Related]  

  • 14. IgA nephropathy: a long-term progressive study.
    Orłowski T; Górski A; Rancewicz Z; Morzycka-Michalik M; Smogorzewski M; Małdyk M; Lao M; Szczesny-Nowicka B
    Miner Electrolyte Metab; 1990; 16(1):54-6. PubMed ID: 2325593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of the angiotensin-converting enzyme inhibitor enalapril on the rates of progression of chronic kidney failure in patients with different degrees of functional kidney disorders].
    Esaian AM; Kaiukov IG; Titova VA
    Ter Arkh; 1995; 67(6):57-9. PubMed ID: 7667785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of triple therapy on the progression of mesangial proliferative glomerulonephritis.
    Woo KT; Edmondson RP; Yap HK; Wu AY; Chiang GS; Lee EJ; Pwee HS; Lim CH
    Clin Nephrol; 1987 Feb; 27(2):56-64. PubMed ID: 3549083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the superiority of immunosuppressive drugs and prednisone over prednisone alone in lupus nephritis. Results of a pooled analysis.
    Felson DT; Anderson J
    N Engl J Med; 1984 Dec; 311(24):1528-33. PubMed ID: 6390198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy.
    Roccatello D; Ferro M; Coppo R; Giraudo G; Quattrocchio G; Piccoli G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2054-9. PubMed ID: 8643167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of primary chronic glomerulonephritis].
    Risler T; Braun N; Erley CM
    Ther Umsch; 1994 Dec; 51(12):807-12. PubMed ID: 7784993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glomerular tip lesion: a steroid responsive nephrotic syndrome.
    Beaman M; Howie AJ; Hardwicke J; Michael J; Adu D
    Clin Nephrol; 1987 May; 27(5):217-21. PubMed ID: 3594937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.